Temat: "Hematopoietic Stem Cell Transplantation" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes.
Autorzy:: Chen J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Pang A; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Liu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Ma R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Chen X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Yang D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhai W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Ma Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Zhou J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.
Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 293-299.
Typ publikacji:: Journal Article
MeSH Terms:: Graft Rejection/*physiopathology
Hematopoietic Stem Cell Transplantation/*adverse effects
Transplantation Conditioning/*adverse effects
Transplantation, Homologous/*adverse effects
Adolescent ; Adult ; Case-Control Studies ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Male ; Middle Aged ; Risk Factors ; Transplantation Conditioning/methods ; Transplantation, Homologous/methods ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis.
Autorzy:: Edahiro T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Kawase T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Nagoshi H; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Fujino K; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Toishigawa K; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Miyama T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Mino T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Yoshida T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Morioka T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Hirata Y; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Noma M; Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Fujii T; Division of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Nishizawa M; Next Generation Development of Genome and Cellular Therapy Program, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Fukushima N; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.; Next Generation Development of Genome and Cellular Therapy Program, Research Institute for Radiation Biology and Medicine (RIRBM), Hiroshima University, Hiroshima, Japan.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 186-198.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Transplantation Conditioning*/adverse effects
Transplantation Conditioning*/methods
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hematologic Neoplasms/*therapy
Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Busulfan/administration & dosage ; Combined Modality Therapy ; Female ; Graft vs Host Disease/diagnosis ; Graft vs Host Disease/etiology ; Hematologic Neoplasms/diagnosis ; Hematologic Neoplasms/mortality ; Humans ; Male ; Melphalan/administration & dosage ; Middle Aged ; Myeloablative Agonists/administration & dosage ; Recurrence ; Remission Induction ; Retrospective Studies ; Survival Analysis ; Transplantation, Homologous ; Treatment Outcome ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A comparative study of porcine antihuman lymphocyte globulin versus antithymocyte globulin-fresenius in an allogeneic hematopoietic cell transplantation conditioning regimen for severe aplastic anemia.
Autorzy:: Zhang Y; Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, People's Republic of China.; The Second People's Hospital of Huai'an, Huai'an, People's Republic of China.
Liu L; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Si Y; Department of Hematology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, People's Republic of China.; The Second People's Hospital of Huai'an, Huai'an, People's Republic of China.
Miao M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Tang X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Fu C; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Jin Z; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Sun A; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.
Wu D; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.; Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 741-750.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Anemia, Aplastic/*therapy
Antilymphocyte Serum/*therapeutic use
Hematopoietic Stem Cell Transplantation/*methods
Transplantation Conditioning/*methods
Adolescent ; Adult ; Animals ; Antilymphocyte Serum/adverse effects ; Child ; Child, Preschool ; Female ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Swine ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects ; Transplantation, Homologous/methods ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts.
Autorzy:: Lu Y; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Xiong M; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Sun RJ; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Zhao YL; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Zhang JP; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Cao XY; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Liu DY; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Wei ZJ; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Zhou JR; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.
Lu DP; Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 134-143.
Typ publikacji:: Journal Article
MeSH Terms:: Congenital Bone Marrow Failure Syndromes/*therapy
Hematopoietic Stem Cell Transplantation/*methods
Transplantation Conditioning/*methods
Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Graft Survival ; Graft vs Host Disease/etiology ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Male ; Survival Analysis ; Transplantation Conditioning/adverse effects ; Unrelated Donors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Successful allogeneic stem cell transplantation with fludarabine-based reduced intensity conditioning in bone marrow failure syndrome 4.
Autorzy:: Barhoom D; Pediatric Cell and Gene Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Pediatric Hematopoietic Stem Cell Transplant Department, Children's Hospital, Damascus University, Damascus, Syria.
Mohseni R; Pediatric Cell and Gene Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Behfar M; Pediatric Cell and Gene Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2021 Nov; Vol. 25 (7), pp. e14089. Date of Electronic Publication: 2021 Jul 24.
Typ publikacji:: Case Reports
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Antineoplastic Agents/*therapeutic use
Bone Marrow Failure Disorders/*therapy
Immunologic Deficiency Syndromes/*therapy
Transplantation Conditioning/*methods
Vidarabine/*analogs & derivatives
Child ; Female ; Humans ; Transplantation, Homologous ; Vidarabine/therapeutic use

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
Autorzy:: Atay D; Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation Unit, Acıbadem University, Istanbul, Turkey.
Akcay A; Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation Unit, Acıbadem University, Istanbul, Turkey.
Akinci B; Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation Unit, Acıbadem University, Istanbul, Turkey.
Yenigurbuz FD; Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation Unit, Acıbadem University, Istanbul, Turkey.
Ovali E; Acibadem Labcell Cellular Therapy Laboratory, Istanbul, Turkey.
Ozturk G; Department of Pediatric Hematology/Oncology & Bone Marrow Transplantation Unit, Acıbadem University, Istanbul, Turkey.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2021 Dec; Vol. 25 (8), pp. e14120. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Mesenchymal Stem Cell Transplantation*
Graft vs Host Disease/*prevention & control
Primary Immunodeficiency Diseases/*therapy
Receptors, Antigen, T-Cell, alpha-beta/*metabolism
Transplantation Conditioning/*methods
Child ; Child, Preschool ; Female ; Graft Rejection ; Humans ; Infant ; Male

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.
Autorzy:: Hahn L; Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Lim H; Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, SK, Canada.
Dusyk T; Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Sabry W; Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Elemary M; Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Stakiw J; Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Danyluk P; Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Bosch M; Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, Saskatoon, SK, Canada. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jul 07; Vol. 11 (1), pp. 14071. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Hematopoietic Stem Cell Transplantation/*methods
Neoplasms/*therapy
Transplantation Conditioning/*methods
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carmustine ; Cytarabine ; Etoposide ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Male ; Melphalan ; Middle Aged ; Neoplasms/diagnosis ; Neoplasms/mortality ; Outcome Assessment, Health Care ; Podophyllotoxin ; Transplantation Conditioning/adverse effects
SCR Protocol:: BEAM protocol; BEAM regimen

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Safety and efficacy of a nonmyeloablative pretransplant conditioning regimen using total lymphoid irradiation with volumetric modulated arc therapy in healthy dogs: A pilot study.
Autorzy:: Kim S; Laboratory of Veterinary Surgery, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Hosoya K; Laboratory of Advanced Veterinary Medicine, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Fukayama N; Laboratory of Advanced Veterinary Medicine, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Deguchi T; Graduate School of Veterinary Medicine, Veterinary Teaching Hospital, Hokkaido University, Sapporo, Japan.
Okumura M; Laboratory of Veterinary Surgery, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.; Pokaż więcej
Źródło:: Veterinary medicine and science [Vet Med Sci] 2021 Jul; Vol. 7 (4), pp. 1120-1130. Date of Electronic Publication: 2021 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Dogs/*surgery
Hematopoietic Stem Cell Transplantation/*veterinary
Lymphatic Irradiation/*veterinary
Radiotherapy, Intensity-Modulated/*veterinary
Transplantation Conditioning/*veterinary
Animals ; Hematopoietic Stem Cell Transplantation/methods ; Male ; Pilot Projects ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.
Autorzy:: Lima ACM; Immunogenetics Laboratory, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Bonfim C; Bone Marrow Transplantation Unit, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Getz J; Immunogenetics Laboratory, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Dornelles LN; Immunogenetics Laboratory, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
do Amaral GB; Immunogenetics Laboratory, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Petterle RR; Department of Integrative Medicine, Federal University of Paraná, Curitiba, Brazil.
Loth G; Bone Marrow Transplantation Unit, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Nabhan SK; Bone Marrow Transplantation Unit, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Pereira NF; Immunogenetics Laboratory, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Pasquini R; Bone Marrow Transplantation Unit, Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.; Pokaż więcej
Źródło:: HLA [HLA] 2021 Jun; Vol. 97 (6), pp. 493-504. Date of Electronic Publication: 2021 May 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Alleles ; Cyclophosphamide ; Humans ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation.
Autorzy:: Gjaerde LK; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Ostrowski SR; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Minculescu L; Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Andersen NS; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Friis LS; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Kornblit B; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Petersen SL; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Schjødt I; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Sengeløv H; Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2021 Mar; Vol. 106 (3), pp. 417-424. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Transplantation Conditioning*/adverse effects
Transplantation Conditioning*/methods
Graft vs Host Disease/*blood
Graft vs Host Disease/*etiology
Vitamin E/*blood
Acute Disease ; Biomarkers ; Disease Susceptibility ; Female ; Graft vs Host Disease/diagnosis ; Humans ; Male ; Myeloablative Agonists/administration & dosage ; Postoperative Period ; Severity of Illness Index ; Time Factors ; Transplantation, Homologous

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in pediatric patient with IL10 receptor deficiency.
Autorzy:: Kheder M; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Pediatric Stem Cell Transplant Department, Children's Hospital, Damascus University, Damascus, Syria.
Behfar M; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Farajifard H; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Immunology-Microbiology Department, Qom University of Medical Sciences and Health Services, Qom, Iran.
Ali T; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Pediatric Stem Cell Transplant Department, Children's Hospital, Damascus University, Damascus, Syria.
Hkima Abou Fakher F; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Pediatric Stem Cell Transplant Department, Children's Hospital, Damascus University, Damascus, Syria.
Hamidieh AA; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2021 Mar; Vol. 25 (2), pp. e13819. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji:: Case Reports
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Myeloablative Agonists/*therapeutic use
Primary Immunodeficiency Diseases/*therapy
Receptors, Interleukin-10/*deficiency
Transplantation Conditioning/*methods
Vidarabine/*analogs & derivatives
Child ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Genetic Markers ; Humans ; Injections, Intravenous ; Primary Immunodeficiency Diseases/genetics ; Receptors, Interleukin-10/genetics ; Vidarabine/therapeutic use

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin's lymphoma patients.
Autorzy:: Tian C; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. .
Li Y; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Liu S; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Chen Z; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Zhang Y; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Yu Y; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Yang H; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Zhao H; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Zhao Z; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Yuan T; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Wang Y; Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Feb 19; Vol. 11 (1), pp. 4273. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Transplantation Conditioning*/adverse effects
Transplantation Conditioning*/methods
Antibiotics, Antineoplastic/*administration & dosage
Idarubicin/*administration & dosage
Lymphoma, Non-Hodgkin/*therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Disease Management ; Female ; Humans ; Lymphoma, Non-Hodgkin/diagnosis ; Lymphoma, Non-Hodgkin/mortality ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Invasiveness ; Neoplasm Staging ; Prognosis ; Transplantation, Autologous ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Autorzy:: Nagler A; Hematology Division, Chaim Sheba Medical Center, 52621, Tel Hashomer, Israel. .
Labopin M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Houhou M; ALWP of the EBMT Paris office, Paris, France.
Aljurf M; King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Mousavi A; Shariati Hospital, Hematology-Oncology and BMT Research, Tehran, Islamic Republic of Iran.
Hamladji RM; Service Hématologie Greffe de Moëlle, Centre Pierre Et Marie Curie, Alger, Algeria.
Al Zahrani M; King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Bondarenko S; Raisa Gorbacheva Memorial Institute of Children Oncology Hematology and Transplantation, First Pavlov State Medical University, Saint-Petersburg, Russian Federation.
Arat M; Hematopoietic Stem Cell Transplantation Unit, Sisli Florence Nightingale Hospital, Istanbul, Turkey.
Angelucci E; Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Koc Y; Medicana International, Istanbul, Turkey.
Gülbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Sica S; Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.; Istituto di Ematologia, Università Cattolica del Sacro Cuore, Rome, France.
Bourhis JH; Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.
Canaani J; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Brissot E; Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France.
Giebel S; Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Mohty M; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2021 Apr 01; Vol. 14 (1), pp. 53. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Hematopoietic Stem Cell Transplantation/*methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*methods
Transplantation, Haploidentical/*methods
Adolescent ; Adult ; Aged ; Europe ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Retrospective Studies ; Siblings ; Survival Analysis ; Tissue Donors ; Transplantation Conditioning/mortality ; Transplantation, Haploidentical/mortality ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major.
Autorzy:: Vellaichamy Swaminathan V; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.
Ravichandran N; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.
Ramanan KM; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.
Meena SK; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.
Varla H; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.
Ramakrishnan B; Department of Biostatistics, Apollo Cancer Institutes, Chennai, India.
Jayakumar I; Department of Pediatric Intensive Care, Apollo Cancer Institutes, Chennai, India.
Uppuluri R; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.
Raj R; Department of Paediatric Hematology, Oncology and Blood and Marrow Transplantation, Apollo Cancer Institutes, Chennai, India.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2021 Mar; Vol. 25 (2), pp. e13893. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji:: Journal Article
MeSH Terms:: Cyclophosphamide/*therapeutic use
Hematopoietic Stem Cell Transplantation/*methods
Immunosuppression Therapy/*methods
Immunosuppressive Agents/*therapeutic use
Transplantation Conditioning/*methods
Transplantation, Haploidentical/*methods
beta-Thalassemia/*therapy
Adolescent ; Child ; Child, Preschool ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Graft Rejection/immunology ; Graft Rejection/prevention & control ; Graft vs Host Disease/immunology ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Male ; Retrospective Studies ; Treatment Outcome ; beta-Thalassemia/mortality

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Irradiation-free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromes.
Autorzy:: Wang YM; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Anderson E; UCSD School of Medicine, La Jolla, CA, USA.; Rady Children's Hospital, San Diego, CA, USA.
Gloude N; UCSD School of Medicine, La Jolla, CA, USA.; Rady Children's Hospital, San Diego, CA, USA.
Marion A; Rady Children's Hospital, San Diego, CA, USA.
King C; Rady Children's Hospital, San Diego, CA, USA.
Leung W; Duke-NUS Medical School, Singapore, Singapore.
Schiff D; UCSD School of Medicine, La Jolla, CA, USA.; Rady Children's Hospital, San Diego, CA, USA.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2021 Mar; Vol. 25 (2), pp. e13855. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Bone Marrow Failure Disorders/*therapy
Myeloablative Agonists/*therapeutic use
Transplantation Conditioning/*methods
Adolescent ; Child ; Child, Preschool ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Graft vs Host Disease/prevention & control ; Humans ; Infant ; Male ; Retrospective Studies ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis.
Autorzy:: Ma L; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Han X; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Jiang S; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Meng Q; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Zhang L; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.
Bao H; Department of Hematology, Second Affiliated Hospital of Nanjing Medical University, 121# Jiangjiayuan Road, Nanjing 210011, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2020 Dec; Vol. 25 (1), pp. 356-365.
Typ publikacji:: Comparative Study; Journal Article; Systematic Review; Video-Audio Media
MeSH Terms:: Graft vs Host Disease*/etiology
Graft vs Host Disease*/mortality
Graft vs Host Disease*/therapy
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Unrelated Donors*
Adult ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model.
Autorzy:: Graves SS; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Storb R; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; University of Washington School of Medicine, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Veterinary and comparative oncology [Vet Comp Oncol] 2020 Dec; Vol. 18 (4), pp. 471-483. Date of Electronic Publication: 2020 May 26.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Transplantation Conditioning*/methods
Transplantation Conditioning*/veterinary
Dog Diseases/*therapy
Hematopoietic Stem Cell Transplantation/*veterinary
Animals ; Bone Marrow Transplantation/methods ; Bone Marrow Transplantation/veterinary ; Dogs ; Graft vs Host Disease/prevention & control ; Graft vs Host Disease/veterinary ; Hematopoietic Stem Cell Transplantation/methods ; Neoplasms/therapy ; Neoplasms/veterinary

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation.
Autorzy:: Polverelli N; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Farina M; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
D'Adda M; Hematology Division, Department of Oncology, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Damiani E; 2nd Division of General Surgery, Department of Medical & Surgical Sciences, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Grazioli L; Department of Radiology, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Leoni A; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Malagola M; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Bernardi S; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.; CREA Laboratory (Centro di Ricerca Emato-Oncologica AIL), ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.
Russo D; Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, P.le Spedali Civili 1, 25123 Brescia, BS, Italy.; Pokaż więcej
Źródło:: Cells [Cells] 2022 Feb 05; Vol. 11 (3). Date of Electronic Publication: 2022 Feb 05.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Hematopoietic Stem Cell Transplantation/*methods
Primary Myelofibrosis/*therapy
Transplantation Conditioning/*methods
Transplantation, Homologous/*methods
Aged ; Aged, 80 and over ; Humans ; Primary Myelofibrosis/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathies.
Autorzy:: Shin SH; Department of Hematology, Hematology Institute, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Park SS; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Park S; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Jeon YW; Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Yoon JH; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Yahng SA; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cho BS; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim YJ; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee S; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim HJ; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Min CK; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cho SG; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim DW; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee JW; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Eom KS; Leukemia Research Institute, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2020 Oct; Vol. 105 (4), pp. 387-398. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Siblings*
Transplantation Conditioning*/adverse effects
Transplantation Conditioning*/methods
Hemoglobinopathies/*therapy
Hemoglobinopathies/diagnosis ; Hemoglobinopathies/mortality ; Humans ; Prognosis ; Transplantation Chimera ; Transplantation, Homologous ; Treatment Outcome ; beta-Thalassemia/mortality ; beta-Thalassemia/therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project.
Autorzy:: Ribaut J; Department Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.; Department of Hematology, University Hospital of Basel, 4031, Basel, Switzerland.
Leppla L; Department Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.; Departments of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, 79110, Freiburg im Breisgau, Germany.
Teynor A; Department of Computer Science, University of Applied Sciences, Augsburg, Germany.
Valenta S; Department Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.; Department of Hematology, University Hospital of Basel, 4031, Basel, Switzerland.
Dobbels F; Department Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.; Academic Center for Nursing and Midwifery, Department of Public Health and Primary Care, University of Leuven, 3000, Leuven, Belgium.
Zullig LL; Department of Population Health Science, Duke University, Durham, NC, USA.; Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, NC, USA.
De Geest S; Department Public Health, Faculty of Medicine, Institute of Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland. .; Academic Center for Nursing and Midwifery, Department of Public Health and Primary Care, University of Leuven, 3000, Leuven, Belgium. .; Pokaż więcej
Corporate Authors:: SMILe study team
Źródło:: BMC health services research [BMC Health Serv Res] 2020 Sep 02; Vol. 20 (1), pp. 827. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Implementation Science*
Medication Adherence*
Transplantation Conditioning*
Telemedicine/*methods
Humans ; Immunosuppressive Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hematopoietic Stem Cell Transplantation"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język